Recently, Cleo et al. reported that soluble VEGF receptor 1, a natural decoy inhibitor of VEGF-A, ameliorates skin lesions and inflammation in an AD model of APOC1 transgenic mice. The gene discussed is VEGFA; the disease is Alzheimer disease.